UA110512C2 - Композиція вірусного інгібітора для терапевтичного застосування - Google Patents

Композиція вірусного інгібітора для терапевтичного застосування

Info

Publication number
UA110512C2
UA110512C2 UAA201311023A UAA201311023A UA110512C2 UA 110512 C2 UA110512 C2 UA 110512C2 UA A201311023 A UAA201311023 A UA A201311023A UA A201311023 A UAA201311023 A UA A201311023A UA 110512 C2 UA110512 C2 UA 110512C2
Authority
UA
Ukraine
Prior art keywords
dna
pharmaceutical composition
formula
obolonkov
digidroxy
Prior art date
Application number
UAA201311023A
Other languages
English (en)
Inventor
Christine Coppens
Original Assignee
Cesa Alliances S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2011/054758 external-priority patent/WO2011117424A1/en
Application filed by Cesa Alliances S A filed Critical Cesa Alliances S A
Publication of UA110512C2 publication Critical patent/UA110512C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/04—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aldehyde or keto groups, or thio analogues thereof, directly attached to an aromatic ring system, e.g. acetophenone; Derivatives thereof, e.g. acetals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
    • A01N37/38—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system
    • A01N37/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system having at least one carboxylic group or a thio analogue, or a derivative thereof, and one oxygen or sulfur atom attached to the same aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/24—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
    • C07C49/245—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings
    • C07C49/248—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Винахід стосується фармацевтичної композиції, яка містить сполуку формули А, яка являє собою (2,3(дигідрокси)-5-[3(1,2)бутадієн]-1-(3-гідрокси-3-метил-4-пентен)бензол), і/або сполуку формули В, що являє собою (2,3-(дигідрокси)-5-[3-(1,2)-бутадієн]-2-[2-метилбутан]бензеналь), і/або сполуку формули С, що являє собою (2,3-(дигідрокси)-5-[3-(1,2)-бутадієн]-2-гідрокси-3-бутенбензоат), або їх комбінацію, для застосування як лікарського препарату або для застосування in vivo при лікуванні або попередженні захворювань, викликаних вірусами з ДНК і з оболонкою, з ДНК і без оболонки, з РНК і з оболонкою і з РНК і без оболонки.
UAA201311023A 2011-03-28 2011-09-27 Композиція вірусного інгібітора для терапевтичного застосування UA110512C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2011/054758 WO2011117424A1 (en) 2010-03-26 2011-03-28 Viral inhibitor compositions for in vivo therapeutic use comprising a combination of (-) -carvone, geraniol and a further essential oil component
PCT/EP2011/066746 WO2012038553A1 (en) 2011-03-28 2011-09-27 Viral inhibitor composition for in vivo therapeutic use

Publications (1)

Publication Number Publication Date
UA110512C2 true UA110512C2 (ru) 2016-01-12

Family

ID=44677899

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201311023A UA110512C2 (ru) 2011-03-28 2011-09-27 Композиція вірусного інгібітора для терапевтичного застосування

Country Status (26)

Country Link
US (1) US9315448B2 (ru)
EP (1) EP2691088B1 (ru)
JP (1) JP5701445B2 (ru)
KR (1) KR101818286B1 (ru)
CN (1) CN103458883B (ru)
AU (1) AU2011306879B2 (ru)
BR (1) BR112013024457A2 (ru)
CA (1) CA2830703C (ru)
CO (1) CO6771455A2 (ru)
DK (1) DK2691088T3 (ru)
EA (1) EA025610B1 (ru)
ES (1) ES2538011T3 (ru)
HK (1) HK1188715A1 (ru)
HR (1) HRP20150596T1 (ru)
IL (1) IL228444A (ru)
MA (1) MA34975B1 (ru)
MX (1) MX2013011242A (ru)
NZ (1) NZ615613A (ru)
PL (1) PL2691088T3 (ru)
PT (1) PT2691088E (ru)
RS (1) RS54022B1 (ru)
SG (1) SG193426A1 (ru)
SI (1) SI2691088T1 (ru)
SM (1) SMT201500131B (ru)
UA (1) UA110512C2 (ru)
WO (1) WO2012038553A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112280750B (zh) * 2020-10-22 2022-11-01 山东农业大学 具有跨种传播能力的新型鹅星状病毒及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU78955A1 (de) 1978-01-27 1979-09-06 Chimicasa Gmbh Verfahren zur inaktivierung von viren
US4902678A (en) 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
US5128353A (en) 1985-06-20 1992-07-07 University Of Florida Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment
US5856364A (en) 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
AU2002217316A1 (en) * 2001-01-03 2002-07-30 Medpharma Plc Use of terpenes for the treatment of digestive tract infections
US20040071757A1 (en) 2001-11-20 2004-04-15 David Rolf Inhalation antiviral patch

Also Published As

Publication number Publication date
KR20140026417A (ko) 2014-03-05
NZ615613A (en) 2014-10-31
IL228444A (en) 2016-10-31
CO6771455A2 (es) 2013-10-15
SG193426A1 (en) 2013-10-30
SMT201500131B (it) 2015-07-09
MA34975B1 (fr) 2014-03-01
HK1188715A1 (en) 2014-05-16
AU2011306879B2 (en) 2016-08-25
KR101818286B1 (ko) 2018-01-12
RS54022B1 (en) 2015-10-30
JP2014517809A (ja) 2014-07-24
HRP20150596T1 (hr) 2015-08-14
EP2691088A1 (en) 2014-02-05
IL228444A0 (en) 2013-12-31
SI2691088T1 (sl) 2015-07-31
EA025610B1 (ru) 2017-01-30
CA2830703C (en) 2016-06-14
AU2011306879A1 (en) 2013-10-10
WO2012038553A1 (en) 2012-03-29
PT2691088E (pt) 2015-07-02
EA201370181A1 (ru) 2014-01-30
CN103458883A (zh) 2013-12-18
CN103458883B (zh) 2015-12-16
EP2691088B1 (en) 2015-03-11
DK2691088T3 (en) 2015-06-15
US20140088193A1 (en) 2014-03-27
PL2691088T3 (pl) 2015-08-31
CA2830703A1 (en) 2012-03-29
BR112013024457A2 (pt) 2020-09-29
JP5701445B2 (ja) 2015-04-15
ES2538011T3 (es) 2015-06-16
US9315448B2 (en) 2016-04-19
MX2013011242A (es) 2013-10-17

Similar Documents

Publication Publication Date Title
PA8827001A1 (es) Derivados de indazol sustituidos con fenilo y benzodioxinilo
CL2017003245A1 (es) Derivados de piperidina 1,4-sustituidos
BR112014030473A2 (pt) novo diazaespirocicloalcano e azaespirocicloalcano
CY1117915T1 (el) Συγχωνευμενες βενζοξαζεπινονες ως διαμορφωτες διαυλων ιοντων
SMT201600174B (it) Forme solide di acido 3-(6-(1-(2,2-difluorobenzo[d][1,3]diossol-5-il)ciclopropancarbossammido)-3-metilpiridin-2-il)benzoico
BR112013028487A2 (pt) inibidores do vírus da hepatite c
CU24315B1 (es) Nuevos derivados de 5-(2- {[3-(aminometil)-3,4-dihidroisoquin0-2(1 h)il] carbonil} fenil)-1 h-pirrol-3-carboxamida como inhibidores de bcl-2 y las composiciones farmacéuticas que los contienen
BR112014004219A2 (pt) pirano[3,2-d][1,3]tiazol como inibidores de glicosidase
BR112012030711A2 (pt) derivado de purinona
CL2011000242A1 (es) Uso de compuestos derivados de fenilaminopirimidina para tratar talasemia alfa, delta y anemia celular falciforme, talasemia mayor, talasemia menor, talasemia e-beta o talasemia beta falciforme, o para mejorar o retrasar los sintomas de las mismas y uso de un compuesto especifico para tratar la talasemia.
UY33735A (es) Compuestos antivirales
EA201391822A1 (ru) Новые производные пиридина
EA201171174A1 (ru) Ингибиторы репликации вируса гепатита c
BR112012033350A2 (pt) "composição e métodos para modular a via de sinalização de wnt"
BR112012021771A2 (pt) métodos de uso de inibidores de contransportadores de sódio-glicose 1 e 2.
BR112014018355A8 (pt) Composto inibidor de quinase reguladora de sinal de apoptose, composição farmacêutica compreendendo o referido composto, uso e compostos intermediários do mesmo
SV2011003903A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa iv para el tratamiento o prevencion de diabetes
BR112015003742A2 (pt) sistema de montagem de componente de descarga
EA201291317A1 (ru) Тетрагидропиридопиримидиновые производные
MA35089B1 (fr) Inhibiteurs de la production de leucotrienes de type benzodioxane
EA201070182A1 (ru) Алкилсульфонилзамещённые тиазолидные соединения
BRPI0812222A2 (pt) Compostos ciclobutenodiona substituídos anti-inflamatórios.
EA201590854A1 (ru) Пиридин-2-амиды, пригодные в качестве агонистов каннабиноидного рецептора 2
BR112013031405A2 (pt) piridopirazinas substituídas como novos inibidores de syk
BR112014009282A2 (pt) ácido de meldrum, ácido barbitúrico e derivados de pirazol substituídos com hidroxilamina como doadores de hno